Pacemaker Therapy: Multimedia

References

1. Cecchin F, Frangini PA, Brown DW, et al. Cardiac Resynchronization Therapy (and Multisite Pacing) in Pediatrics and Congenital Heart Disease: Five Years Experience in a Single Institution. J Cardiovasc Electrophysiol. Sep 3 2008;[Medline].

2. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. Dec 20 2005;46(12):2277-83. [Medline].

3. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. May 27 2008;51(21):e1-62. [Medline].

4. Fishberger SB, Wernovsky G, Gentles TL, et al. Long-term outcome in patients with pacemakers following the Fontan operation. Am J Cardiol. Apr 15 1996;77(10):887-9. [Medline].

5. Berul CI, Hill SL, Estes NA 3rd. A teenager with pacemaker twiddler syndrome. J Pediatr. Sep 1997;131(3):496-7. [Medline].

6. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. Jan 2004;15(1):72-6. [Medline].

7. Alpern D, Uzark K, Dick M 2nd. Psychosocial responses of children to cardiac pacemakers. J Pediatr. Mar 1989;114(3):494-501. [Medline].

8. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet. Dec 3 1994;344(8936):1523-8. [Medline].

9. Benjacholamas V, Chotivittayatarakorn P, Lertsupchareon P, et al. Single midline approach for permanent pacemaker implantation in children. Asian Cardiovasc Thorac Ann. Mar 2003;11(1):11-3. [Medline].

10. Berul C, Hill S, Mack K. VDDR pacing in children and young adults. HeartWeb. 1998;4:110002-8.

11. Berul CI, Barrett KS. Unique Aspects of Pacemaker Implantation in Pediatrics. In: Walsh EP, Saul JP, Triedman JK (Editors). Current Concepts of Pediatric Electrophysiology. Baltimore: Lippincott Williams & Wilkins; 2001:301-317.

12. Berul CI, Cecchin F. Indications and techniques of pediatric cardiac pacing. Expert Rev Cardiovasc Ther. Jul 2003;1(2):165-76. [Medline].

13. Berul CI, Murphy JD. Nocturnal enuresis secondary to heart block: report of cure by cardiac pacemaker implantation. Pediatrics. Aug 1993;92(2):284-5. [Medline].

14. Bevilacqua L, Hordof A. Cardiac pacing in children. Curr Opin Cardiol. Jan 1998;13(1):48-55. [Medline].

15. Bruckheimer E, Berul CI, Kopf GS, et al. Late recovery of surgically-induced atrioventricular block in patients with congenital heart disease. J Interv Card Electrophysiol. Jun 2002;6(2):191-5. [Medline].

16. Case CL, Gillette PC, Zeigler V, Sade RM. Problems with permanent atrial pacing in the Fontan patient. Pacing Clin Electrophysiol. Jan 1989;12(1 Pt 1):92-6. [Medline].

17. Chintala K, Forbes TJ, Karpawich PP. Effectiveness of transvenous pacemaker leads placed through intravascular stents in patients with congenital heart disease. Am J Cardiol. Feb 1 2005;95(3):424-7. [Medline].

18. Connolly SJ, Kerr C, Gent M, Yusuf S. Dual-chamber versus ventricular pacing. Critical appraisal of current data. Circulation. Aug 1 1996;94(3):578-83. [Medline].

19. DeMaso DR, Lauretti A, Spieth L, et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol. 2004;93:582-7. [Medline].

20. Epstein MR, Walsh EP, Saul JP, et al. Long-term performance of bipolar epicardial atrial pacing using an active fixation bipolar endocardial lead. Pacing Clin Electrophysiol. May 1998;21(5):1098-104. [Medline].

21. Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. Oct 2005;14(1):27-36. [Medline].

22. Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. Jul 2004;1(2):150-9. [Medline].

23. Friedman RA, Moak JP, Garson A Jr. Active fixation of endocardial pacing leads: the preferred method of pediatric pacing. Pacing Clin Electrophysiol. Aug 1991;14(8):1213-6. [Medline].

24. Friedman RA, Van Zandt H, Collins E, LeGras M, Perry J. Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin Electrophysiol. May 1996;19(5):778-83. [Medline].

25. Galdston R, Gamble WJ. On borrowed time: observations on children with implanted cardiac pacemakers and their families. Am J Psychiatry. Jul 1969;126(1):104-8. [Medline].

26. Gillette PC, Zeigler VL, Winslow AT, Kratz JM. Cardiac pacing in neonates, infants, and preschool children. Pacing Clin Electrophysiol. Nov 1992;15(11 Pt 2):2046-9. [Medline].

27. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakersand antiarrhythmia devices: summary article: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee t. Circulation. Oct 15 2002;106(16):2145-61. [Medline].

28. Gregoratos G, Cheitlin MD, Conill A. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol. Apr 1998;31(5):1175-209. [Medline].

29. Horenstein MS, Karpawich PP. Pacemaker syndrome in the young: do children need dual chamber as the initial pacing mode?. Pacing Clin Electrophysiol. May 2004;27(5):600-5. [Medline].

30. Lamas GA, Pashos CL, Normand SL, McNeil B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation. Feb 15 1995;91(4):1063-9. [Medline].

31. Lau YR, Gillette PC, Buckles DS, Zeigler VL. Actuarial survival of transvenous pacing leads in a pediatric population. Pacing Clin Electrophysiol. Jul 1993;16(7 Pt 1):1363-7. [Medline].

32. Link MS, Hill SL, Cliff DL, et al. Comparison of frequency of complications of implantable cardioverter- defibrillators in children versus adults. Am J Cardiol. Jan 15 1999;83(2):263-6, A5-6. [Medline].

33. Lukl J, Doupal V, Heinc P. Quality-of-life during DDD and dual sensor VVIR pacing. Pacing Clin Electrophysiol. Nov 1994;acing.(11 Pt 2):1844-8. [Medline].

34. Mathony U, Schmidt H, Groger C, et al. Optimal maximum tracking rate of dual-chamber pacemakers required by children and young adults for a maximal cardiorespiratory performance. Pacing Clin Electrophysiol. May 2005;28(5):378-83. [Medline].

35. Molina JE, Dunnigan AC, Crosson JE. Implantation of transvenous pacemakers in infants and small children. Ann Thorac Surg. Mar 1995;59(3):689-94. [Medline].

36. Mueller X, Sadeghi H, Kappenberger L. Complications after single versus dual chamber pacemaker implantation. Pacing Clin Electrophysiol. Jun 1990;13(6):711-4. [Medline].

37. Noiseux N, Khairy P, Fournier A, Vobecky SJ. Thirty years of experience with epicardial pacing in children. Cardiol Young. Oct 2004;14(5):512-9. [Medline].

38. Ovsyshcher IE, Hayes DL, Furman S. Dual-chamber pacing is superior to ventricular pacing: fact or controversy? [comment]. Circulation. Jun 16 1998;97(23):2368-70. [Medline].

39. Paridon SM, Karpawich PP, Pinsky WW. Exercise performance with single chamber rate-responsive pacing in congenital heart defects after operation. Am J Cardiol. Nov 1 1991;68(11):1231-3. [Medline].

40. Ragonese P, Guccione P, Drago F, et al. Efficacy and safety of ventricular rate responsive pacing in children with complete atrioventricular block. Pacing Clin Electrophysiol. Apr 1994;17(4 Pt 1):603-10. [Medline].

41. Rosenthal E, Bostock J. Use of an atrial loop to extend the duration of endocardial pacing in a neonate. Pacing Clin Electrophysiol. Oct 1997;20(10 Pt 1):2489-91. [Medline].

42. Serwer GA, Mericle JM, Armstrong BE. Epicardial ventricular pacemaker electrode longevity in children. Am J Cardiol. Jan 1 1988;61(1):104-6. [Medline].

43. Silka MJ, Bar-Cohen Y. Pacemakers and implantable cardioverter-defibrillators in pediatric patients. Heart Rhythm. Nov 2006;3(11):1360-6. [Medline].

44. Silvetti MS, Drago F. Upgrade of single chamber pacemakers with transvenous leads to dual chamber pacemakers in pediatric and young adult patients. Pacing Clin Electrophysiol. Aug 2004;27(8):1094-8. [Medline].

45. Smerup M, Hjertholm T, Johnsen SP, et al. Pacemaker implantation after congenital heart surgery: risk and prognosis in a population-based follow-up study. Eur J Cardiothorac Surg. Jul 2005;28(1):61-8. [Medline].

46. Spotnitz HM. Transvenous pacing in infants and children with congenital heart disease. Ann Thorac Surg. Mar 1990;49(3):495-6. [Medline].

47. Stojanov P, Vranes M, Velimirovic D, et al. Prevalence of venous obstruction in permanent endovenous pacing in newborns and infants: follow-up study. Pacing Clin Electrophysiol. May 2005;28(5):361-5. [Medline].

48. Sutton R, Bourgeois I. Cost benefit analysis of single and dual chamber pacing for sick sinus syndrome and atrioventricular block. An economic sensitivity analysis of the literature. Eur Heart J. Apr 1996;17(4):574-82. [Medline].

Further Reading

Keywords

pacemaker therapy, pacing, permanent pacing, pacemaker implantation, transvenous pacemaker, implanted cardioverter/defibrillator, ICD, congenital heart disease, sinus node dysfunction, atrioventricular node function, heart rate, long QT syndrome, cardiomyopathy, cardiac resynchronization therapy, CRT, congenital atrioventricular block, acquired atrioventricular block, congenital AV block, acquired AV block, systemic lupus erythematosus, SLE, congenital heart block, Lyme disease, viral myocarditis, symptomatic bradycardia, ventricular dysfunction, or low cardiac output, ventricular tachycardia, bradycardia-tachycardia syndrome, tetralogy of Fallot

Contributor Information and Disclosures

Author

Charles I Berul, MD, Associate Professor of Pediatrics, Harvard Medical School; Senior Associate, Department of Cardiology, Children's Hospital of Boston
Charles I Berul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Heart Rhythm Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Coauthor(s)

Jennifer N Avari, MD, Fellow, Pediatric Electrophysiology, Children's Hospital Boston
Jennifer N Avari, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Medical Association, and Heart Rhythm Society
Disclosure: Nothing to disclose.

Medical Editor

Jeffrey Allen Towbin, MD, MSc, FAAP, FACC, FAHA, Professor, Departments of Pediatrics (Cardiology), Cardiovascular Sciences, and Molecular and Human Genetics, Baylor College of Medicine; Chief of Pediatric Cardiology, Foundation Chair in Pediatric Cardiac Research, Texas Children's Hospital
Jeffrey Allen Towbin, MD, MSc, FAAP, FACC, FAHA is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American College of Cardiology, American College of Sports Medicine, American Heart Association, American Medical Association, American Society of Human Genetics, Cardiac Electrophysiology Society, Heart Rhythm Society, New York Academy of Sciences, Society for Pediatric Research, Texas Medical Association, and Texas Pediatric Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

John W Moore, MD, MPH, Professor of Clinical Pediatrics, Division of Pediatric Cardiology, Mattel Children's Hospital of University of California at Los Angeles
John W Moore, MD, MPH is a member of the following medical societies: Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

CME Editor

Gilbert Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College
Gilbert Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Chief Editor

Stuart Berger, MD, Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin
Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.